Thomas Alexander Waldmann

Silver Springs, MD, United States of America

Thomas Alexander Waldmann

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 116(Granted Patents)


Location History:

  • Silver Springs, MD (US) (1999)
  • Silver Spring, MD (US) (1997 - 2014)
  • Bethesda, MD (US) (2021 - 2024)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Thomas Alexander Waldmann

Introduction

Thomas Alexander Waldmann, an accomplished inventor based in Silver Springs, MD, has made significant contributions to the field of biomedical innovation. With a remarkable portfolio of 11 patents, his work primarily focuses on chimeric antigen receptors (CARs), paving the way for new therapeutic approaches.

Latest Patents

Waldmann's latest inventions include a chimeric antigen receptor that targets the chemokine receptor CCR4. This innovative receptor comprises several key components: an scFv consisting of a light chain variable domain and a heavy chain variable domain that specifically binds to CCR4, a hinge and transmembrane domain derived from CD8, an intracellular 4-1BB signaling domain, and an intracellular CD3 zeta signaling domain. Collectively, these elements work synergistically to enhance the receptor's functionality, making it a promising candidate for treating malignancies.

Career Highlights

Throughout his career, Waldmann has worked with esteemed organizations, including the United States of America as represented by the Secretary of the Department of Health and Human Services and the United States of America as represented by the Department of Health. His innovative spirit and dedication have solidified his reputation in the scientific community.

Collaborations

Thomas Alexander Waldmann has collaborated with prominent figures in the industry, including Ira H. Pastan and Cary L. Queen. These partnerships have fostered advancements in their field and have contributed to the development of groundbreaking therapies.

Conclusion

In conclusion, Thomas Alexander Waldmann's contributions to the realm of chimeric antigen receptors exemplify the spirit of innovation. His extensive patent portfolio and impactful collaborations underscore his commitment to advancing medical science and improving treatment options for patients. Waldmann's work not only reflects his personal achievements but also serves as an inspiration for future inventors in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…